Trinomab
Developer of antibody biopharmaceuticals and provider of related research services.
Launch date
Employees
Market cap
-
Enterprise valuation
$413—619m (Dealroom.co estimates Nov 2022.)
Zhuhai Guangdong (HQ)
Authorizing premium user...